Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHLO: CDT with rt-PA for Pediatric DVT
NCT02767232Phase 3Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Jul 2018
- Primary completion
- Apr 2023
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 3 trial of tissue-plasminogen activator in deep vein thrombosis (DVT), sponsored by University of Colorado Denver. Planned start Jul 2018; status: withdrawn.
02
Drugs
tissue-plasminogen activator
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT02767232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767232.